Dyslipoproteinemia and diabetes.
Lipoprotein changes in diabetes are discussed from both a pathophysiologic and clinical viewpoint. Though differences in concentrations are often small and vary according to the type of diabetes, other changes in lipoprotein metabolism are presented. The interrelationships between diabetes, insulin, and heart disease are also discussed, with the central role of insulin being stressed. Finally, the clinical management of lipid disorders in diabetes is addressed.
Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pennsylvania.
T J
TJ
Orchard
D001161:Arteriosclerosis / Q000209:etiology; D002318:Cardiovascular Diseases / Q000209:etiology; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications; D005260:Female; D006801:Humans; D006951:Hyperlipoproteinemias / Q000150:complications* / Q000628:therapy; D007009:Hypolipoproteinemias / Q000150:complications* / Q000628:therapy; D007328:Insulin / Q000097:blood; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008297:Male
D007328:Insulin; D008055:Lipids; D008074:Lipoproteins